Name: Biomarkers Market in 10MM – Market Outlook, Unmet Needs, Market Assessment &amp; Forecast (2023-2030)
SKU: 17084
Availability: InStock

Biomarkers Market – Report Overview

Pacific Business Consulting’s “Biomarkers Market in 10MM – Market Outlook, Unmet Needs, Market Assessment & Forecast (2023-2030)” report offers a comprehensive understanding of Biomarkers market, encompassing historical and projected market size data, along with market trends, market drivers, market barriers and unmet medical needs in the Ten Major Markets (10MM) of the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, China, Australia, and India.

The global Biomarkers market, valued at US$ 24.0 Billion in 2022, is projected to grow at a Compound Annual Growth Rate (CAGR) of more than 10.0% from 2023 to 2030, reaching a value of more than US$ 52.0 Billion by 2030.

Biomarkers play a crucial role in the diagnostics market, particularly in meeting the increasing demand for early diagnosis with accurate and consistent results. They address significant challenges, especially in the early stages of diseases such as cancer, and offer minimally or non-invasive tools for diagnosis. Biomarkers, when integrated with key imaging and data management technologies, are meeting market expectations.

Key applications of biomarkers include risk assessment, molecular diagnostics, disease diagnosis, DNA fingerprinting, and other molecular applications. They enable pharmaceutical companies to analyze and discover novel drugs, contributing to the demand for cost-effective and efficient treatment options. Biomarkers are extensively used in drug validation and testing, sample preparation, and assay development to simplify the discovery and development of novel drugs.

Several factors contribute to the growth of the biomarkers market, including the increasing significance of companion diagnostics, the rise in cancer prevalence, growing investments in biomarker research, and ongoing innovations. For instance, researchers from Boston University received funding from the National Institutes of Health to innovate lung cancer biomarkers in October 2022. Technological advancements in biomarker-based diagnostics also contribute to industry expansion.

Biomarkers are increasingly essential in infectious disease diagnosis. Potential MicroRNA-based biomarkers have been identified for various infections, promoting early detection. Additionally, biomarkers are employed to track brain health, aiding in the treatment of neurological diseases. Public and private investments in biomarker research have increased, leading to advancements and applications in various disease treatments.

Recent developments in biomarkers allow non-invasive testing, quicker drug development, and early diagnosis. Collaborations and programs initiated by leading players, such as Amgen’s Biomarker Assist program, aim to increase the commercialization of biomarker-based products.

Key players in the Biomarkers segment, including GE Healthcare, Eisai Co. Ltd., Siemens AG, Agilent Technologies Inc., Roche Diagnostics Limited, Epistem Ltd., Abbott Laboratories, Inc., Bio-Rad Laboratories, Thermo Fisher Scientific Inc., and Aushon Biosystem, are expected to shape the future landscape of biomarker technologies through ongoing innovation.

Scope of Report

The report addresses critical subjects such as strategic competitor evaluation, market characterization, unmet needs, and the consequences of these elements for the Biomarkers market. It also delves into the analysis of present and prospective market competition within the global Biomarkers market.

Furthermore, the report offers an insightful examination of the primary industry drivers, constraints, and challenges. Each trend undergoes independent research to furnish qualitative analysis regarding its implications.

Reasons to Buy

Develop your business strategies by gaining insights into the trends that shape and drive the Biomarkers market across the 10MM (Ten Major Markets).
Increase revenue by comprehending key trends, innovative products and technologies, market segments, and companies poised to influence the future of the 10MM Biomarkers market.
Craft effective sales and marketing strategies by thoroughly understanding the competitive landscape and analyzing the performance of various competitors.
Identify emerging players with potentially robust product portfolios and devise strategic counter-strategies to gain a competitive advantage.
Optimize your sales and marketing efforts by pinpointing market categories and segments that offer the greatest opportunities for consolidations, investments, and strategic partnerships.

Executive Summary: Biomarkers
- Global Market Outlook: Biomarkers
Competitive Intelligence Analysis: Biomarkers
Therapeutic Sector SWOT
Technology Roadmap Analysis: Biomarkers
Market Background
- Drivers
- Restraints
- Opportunity
- Key Market Trends
- Key Unmet Needs
Key Marketed Products Profile – Major Approved Products: Biomarkers
- Product Profile
- Safety and Efficacy
Regulatory Landscape
Biomarkers: Ten Major Market (10MM) – Market Analysis, By Disease Type
- Cancer
- Neurological Diseases
- Immunological Disorders
- Cardiovascular Diseases
- Others
Biomarkers: Ten Major Market (10MM) – Market Analysis, By Technology
- Omics
- Immunoassay
- Imaging
- Others
Biomarkers: Ten Major Market (10MM) – Market Analysis, By Application
- Drug Delivery
- Diagnostics
- Prognostics
- Others
Biomarkers: Ten Major Market (10MM) – Market Analysis
- Historical Market Analysis (US$ million), 2020-2022
  - By Disease Type
  - By Technology
  - By Application
- Current and Future Market Projections (US$ million), 2023-2030
  - By Disease Type
  - By Technology
  - By Application

S. Biomarkers – Market Analysis
- Historical Market Analysis (US$ million), 2020-2022
  - By Disease Type
  - By Technology
  - By Application
- Current and Future Market Projections (US$ million), 2023-2030
  - By Disease Type
  - By Technology
  - By Application

K. Biomarkers – Market Analysis
- Historical Market Analysis (US$ million), 2020-2022
  - By Disease Type
  - By Technology
  - By Application
- Current and Future Market Projections (US$ million), 2023-2030
  - By Disease Type
  - By Technology
  - By Application

Germany Biomarkers – Market Analysis
- Historical Market Analysis (US$ million), 2020-2022
  - By Disease Type
  - By Technology
  - By Application
- Current and Future Market Projections (US$ million), 2023-2030
  - By Disease Type
  - By Technology
  - By Application

France Biomarkers – Market Analysis
- Historical Market Analysis (US$ million), 2020-2022
  - By Disease Type
  - By Technology
  - By Application
- Current and Future Market Projections (US$ million), 2023-2030
  - By Disease Type
  - By Technology
  - By Application

Italy Biomarkers – Market Analysis
- Historical Market Analysis (US$ million), 2020-2022
  - By Disease Type
  - By Technology
  - By Application
- Current and Future Market Projections (US$ million), 2023-2030
  - By Disease Type
  - By Technology
  - By Application

Spain Biomarkers – Market Analysis
- Historical Market Analysis (US$ million), 2020-2022
  - By Disease Type
  - By Technology
  - By Application
- Current and Future Market Projections (US$ million), 2023-2030
  - By Disease Type
  - By Technology
  - By Application

Japan Biomarkers – Market Analysis
- Historical Market Analysis (US$ million), 2020-2022
  - By Disease Type
  - By Technology
  - By Application
- Current and Future Market Projections (US$ million), 2023-2030
  - By Disease Type
  - By Technology
  - By Application

China Biomarkers – Market Analysis
- Historical Market Analysis (US$ million), 2020-2022
  - By Disease Type
  - By Technology
  - By Application
- Current and Future Market Projections (US$ million), 2023-2030
  - By Disease Type
  - By Technology
  - By Application

Australia Biomarkers – Market Analysis
- Historical Market Analysis (US$ million), 2020-2022
  - By Disease Type
  - By Technology
  - By Application
- Current and Future Market Projections (US$ million), 2023-2030
  - By Disease Type
  - By Technology
  - By Application

India Biomarkers – Market Analysis
- Historical Market Analysis (US$ million), 2020-2022
  - By Disease Type
  - By Technology
  - By Application
- Current and Future Market Projections (US$ million), 2023-2030
  - By Disease Type
  - By Technology
  - By Application

Competitive Landscape
- Company Overview
- Product Portfolio
- Key Financials
- Sales Footprint

Note – All Major Company Profiles (Count up to 20) will be covered in the report

Assumptions and Acronyms Used
Research Methodology
- Secondary Research
- Primary Research
- Data Triangulation
Geographic Scope
- The U.S., The U.K., Germany, France, Italy, Spain, Japan, China, Australia, and India
Copyrights and Disclaimer

Biomarkers Market in 10MM – Market Outlook, Unmet Needs, Market Assessment & Forecast (2023-2030)

License Type (Price in USD)

Customize Reports As Per Your Needs

Have A Question?

Phone:+919599779105
Email:info@pacificbusinessconsulting.com

RELATED PRODUCTS

Alzheimer’s Disease Market in 8MM – Market Outlook, Unmet Needs, Market Assessment and Forecast (2023-2030)

Chronic Lymphocytic Leukemia (CLL) Market in 8MM – Market Outlook, Unmet Needs, Market Assessment and Forecast (2023-2030)

Crohn’s Disease Market in 8MM – Market Insights, Unmet Needs, Market Assessment and Forecast (2023-2030)

Heart Failure (HF) Market in 8MM – Market Insights, Unmet Needs, Market Assessment and Forecast (2023-2030)

Pulmonary Arterial Hypertension (PAH) Market in 8MM – Market Outlook, Unmet Needs, Market Assessment and Forecast (2023-2030)

Useful Links

Consulting

Get In Touch